BROWSE·page 21 of 100

Browse EX-10 agreements

1,194 matching material contract exhibits.


FORM OF LOCK UP AGREEMENT

NuvOx Therapeutics, Inc.

**Exhibit 10.15 **

** **

Lock-Up Agreement

** **

[●], 2026

ThinkEquity LLC

17 State Street, 41st Floor

New York, NY 10004

As Representative of the several Underwriters named on Schedule 1 to the Underwriting Agreement referenced below

Ladies and Gentlemen:

The undersigned understands that ThinkEquity LLC (the “Representative”), proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with NuvOx Therapeutics, Inc., a Delaware corporation (the “Company”), providing for the initial public offering (the “Public Offering”) of shares of common stock, par value $0.001 per share, of the Company (the “Common Shares”).

…

EX-10.15·S-1/A·CIK 1966126·ACC 0001213900-26-100586·Filed Sep 16, 2026, 17:19 ET

EX-10.4

Bitwise NEAR ETF

2NDAMENDMENT TO

MARKETING AGENT AGREEMENT

This 2NDAmendment (this “Amendment”) is entered into as of July 29, 2026 (the “Signing Date”) and effective as of the date specified in Exhibit A to this Amendment with respect to the relevant Trust, or if no such date is specified therein, the Signing Date (the “Effective Date”), by and between:

Foreside Fund Services, LLC, a Delaware limited liability company (“ACA Foreside”); and

Bitwise Investment Advisers, LLC, a Delaware limited liability company in its capacity as sponsor to certain exchange-traded products (the “Sponsor”), for and on behalf of each Trust identified in the Agreement, severally and not jointly.

ACA Foreside and Sponsor are each referred to herein as a “Party,” and collectively as the “Parties.”

WHEREAS, the Parties entered into that certain Marketing Agent Agreement, dated as of February 2, 2026 and effective as of December 31, 2025 (as previously amended, supplemented, or otherwise modified, the “Agreement”); and

WHEREAS, the Parties desire to amend the Agreement as set forth herein;

…

EX-10.4·S-1/A·CIK 2067111·ACC 0001193125-26-393240·Filed Sep 16, 2026, 17:13 ET

EX-10.6

Bitwise NEAR ETF

AMENDMENT TO THE COINBASE PRIME

BROKER AGREEMENT

This Amendment (this “Amendment”), dated as of July 29, 2026, to the Amended Restated and Consolidated Coinbase Prime Broker Agreement, dated August 22, 2025, by and between Coinbase, Inc. (“Coinbase”), on behalf of itself and as agent for Coinbase, Coinbase Custody Trust Company, LLC (“Coinbase Custody”), and, as applicable, Coinbase Credit, Inc. (“Coinbase Credit,”and collectively with Coinbase and Coinbase Custody, the “Coinbase Entities”), and the party or parties identified as a Client thereunder, and Bitwise Investment Advisers, LLC in its capacity as sponsor of the Clients (as such Coinbase Prime Broker Agreement may have been amended from time to time, the “Original Agreement”), is entered into by the Coinbase Entities and each Client identified on Schedule A hereto. Each Coinbase Entity and each Client may be individually referred to as a “Party”and collectively, the “Parties”.

WHEREAS, the Parties desire to amend the Original Agreement as set forth in this Amendment.

…

EX-10.6·S-1/A·CIK 2067111·ACC 0001193125-26-393240·Filed Sep 16, 2026, 17:13 ET

EX-10.13

Bitwise NEAR ETF

ATTESTANT STAKING

MASTER SERVICES AGREEMENT


Exhibit 10.13

TABLE OF CONTENTS

1. Interpretation 1
2. Provider Services 4
3. Eligibility for Services 4
4. Customer anti-money laundering obligations 5
5. Customer general obligations 6

…

EX-10.13·S-1/A·CIK 2067111·ACC 0001193125-26-393240·Filed Sep 16, 2026, 17:13 ET

EXHIBIT 10.1

New Iceland Arctic Acquisition Corp.

[●], 2026

New Iceland Arctic Acquisition Corp.

1300 Jackson Street, Suite 100

Golden, CO 80401

Re: Initial Public Offering

Gentlemen:

This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between New Iceland Arctic Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Chardan Capital Markets, LLC (the “Underwriter”), relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”), each comprised of one Class A ordinary share, par value $0.0001 per share, of the Company (each an “Ordinary Share”), one-half of one redeemable warrant to purchase one Ordinary Share (each whole warrant, a “Warrant”), and one right to receive one-fifth of one Class A ordinary share upon the consummation of the Company’s initial Business Combination (each, a “Right”). Each Warrant entitles the holder thereof to purchase

…

EX-10.1·S-1/A·CIK 2148245·ACC 0001185185-26-004057·Filed Sep 16, 2026, 15:15 ET

Canary Staked SEI ETF S-1/A

Exhibit 10.8

IOPV CALCULATION

AGREEMENT

- hereinafter referred to as the “Agreement” -

between

Solactive AG

Platz der Einheit 1
60327 Frankfurt, Germany

- hereinafter referred to as “Solactive” -

and

Canary Capital Group LLC

1131 4th Ave S #230,

Nashville, TN 37210

- hereinafter referred to as the “Partner” -

dated 02 April, 2025 (the “Agreement Date”)

Solactive and the Partner are hereinafter also referred to individually as a “Party”
and collectively as the “Parties”

Version 2.0. October, 2021

1. PREAMBLE

Solactive is an independent German-based multi-asset class index service provider, operating worldwide and active in the business of calculation, maintenance and dissemination of Indicative Optimized Portfolio Value (“IOPV”).

…

EX-10.8·S-1/A·CIK 2066353·ACC 0001999371-26-020568·Filed Sep 15, 2026, 17:17 ET

** **

Portions of this exhibit, indicated by [***], have been omitted in accordance with Item 601(b)(10)(iv) of Regulation S-K. The omitted information is (i) not material and (ii) treated by the Registrant as private or confidential.

** **

Certain schedules and exhibits to this agreement have been omitted in accordance with Item 601(a)(5) of Regulation S-K.

** **

The Registrant undertakes to furnish a copy of all omitted information, schedules, and exhibits to the U.S. Securities and Exchange Commission upon its request.

** **

AIA Document A141’ 2024

*** ***

***Standard Form of Agreement Between Owner and Design-Builder
***for a Traditional Design-Build Project

…

EX-10.13·S-1/A·CIK 95572·ACC 0001213900-26-099804·Filed Sep 14, 2026, 17:45 ET

Ox Hill / Trinity Group Construction SECURITY AGREEMENT and

Convertible Note Agreement

This Collateral Security Agreement (the “Agreement”) is entered into as of 30th July 2026, by and among:

● **Ox Hill Realty LLC **(the “Developer” or “Debtor”), a Virginia limited liability company (EIN 84-4517361), with its principal place of business at 4031 University Drive, Fairfax, VA, 22030;

…

EX-10.12·S-1/A·CIK 95572·ACC 0001213900-26-099804·Filed Sep 14, 2026, 17:45 ET

VERI MEDTECH HOLDINGS, INC.
STOCK INCENTIVE 2025 PLAN
AMENDED AND RESTATED EFFECTIVE AS OF SEPTEMBER 12, 2026

The name of the plan is the Veri Medtech Holdings, Inc. Stock Incentive 2025 Plan, as amended and restated effective as of September 12, 2026 (the “2025 Plan”). The 2025 Plan was originally effective as of September 30, 2025 and is hereby amended and restated in its entirety effective as of September 12, 2026 (the “Amendment and Restatement Date”).

…

EX-10.6·S-1/A·CIK 2078149·ACC 0001096906-26-001366·Filed Sep 14, 2026, 17:27 ET

STOCK REPURCHASE PLAN

Veri MedTech Holdings, Inc.

202**6 STOCK REPURCHASE PLAN**

VERI MEDTECH HOLDINGS, INC.

JU**LY 15, 202**6

Stock Repurchase Program**: ** The 2026 Program authorizes the Company to repurchase, at any time, up to 3,000,000 shares of its VRHI common stock on the open market, in privately negotiated transactions or otherwise at the Company’s sole discretion.  The 2026 Program may be altered, suspended, or terminated at any time based on various factors including but not limited to market conditions, share price, alternative investment opportunities. The 2026 Program does not obligate or mandate the Company to make any stock purchases of any specific amount, supersedes any other program(s) and continues until terminated.

EX-10.7·S-1/A·CIK 2078149·ACC 0001096906-26-001366·Filed Sep 14, 2026, 17:27 ET

EX-10.20

ADARx Pharmaceuticals, Inc.

***COMMON STOCK PURCHASE AGREEMENT ***

This **COMMON STOCK PURCHASE AGREEMENT **(this “Agreement”) is made as of September 13, 2026 (the “Effective Date”), by and among ADARx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and AbbVie Inc. (the “Investor”).

**RECITALS **

WHEREAS, the Company is proposing to issue and sell to the Investor (the “Financing”) shares of the Company’s common stock, $0.0001 par value per share (“Common Stock”), pursuant to the terms and subject to the conditions set forth in this Agreement.

WHEREAS, the shares of Common Stock are being offered to the Investor pursuant to a private placement exemption from registration pursuant to Section 4(a)(2) under the Securities Act of 1933, as amended (the “Securities Act”).

…

EX-10.20·S-1/A·CIK 1802369·ACC 0001193125-26-390724·Filed Sep 14, 2026, 17:00 ET

EX-10.7

Bamboo Insurance Services, Inc.

BAMBOO INSURANCE SERVICES, INC.2026 INCENTIVE AWARD PLAN

RESTRICTED STOCK UNIT GRANT NOTICE

Capitalized terms not specifically defined in this Restricted Stock Unit Grant Notice (the “GrantNotice”) have the meanings given to them in the 2026 Incentive Award Plan (as amended from time to time, the “Plan”) of Bamboo Insurance Services, Inc. (the “Company”).

…

EX-10.7·S-1/A·CIK 2125355·ACC 0001628280-26-061664·Filed Sep 14, 2026, 06:53 ET